Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
Hypertensive disorders of pregnancy (HDP) are with 50.000 deaths every year one of the major
causes of maternal mortality worldwide, especially in low and middle income countries. This
trial aims to determine whether a daily dose of combined low-dose aspirin, calcium, vitamin
D3, folic acid and vitamin B12 in pregnancy reduces the incidence of pregnancy-induced
hypertension in women at risk. Secondary and tertiary objectives include other maternal and
neonatal outcomes.